AXL receptor tyrosine kinase inhibition improves the anti-tumor effects of CD8


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
05 11 2023
Historique:
received: 10 08 2023
revised: 23 08 2023
accepted: 10 09 2023
medline: 10 10 2023
pubmed: 13 9 2023
entrez: 13 9 2023
Statut: ppublish

Résumé

AXL is a member of TAM receptor family and has been highlighted as a potential target for cancer treatment. Accumulating evidence has uncovered the critical role of the AXL signaling pathway in tumor growth, metastasis, and resistance against anti-cancer drugs, as well as its association with cancer immune escape. However, the function of AXL as a manipulator of the immune system in the tumor microenvironment (TME) remains unclear. Therefore, in this study, we investigated the impact of AXL on immune cells in the TME of a syngeneic tumor model using AXL knockout (AXL

Identifiants

pubmed: 37703603
pii: S0006-291X(23)01051-3
doi: 10.1016/j.bbrc.2023.09.021
pii:
doi:

Substances chimiques

Axl Receptor Tyrosine Kinase 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-14

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Kyungtaek Im (K)

Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, 05505, South Korea.

Yun Jung Choi (YJ)

Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, 05505, South Korea.

Dong Ha Kim (DH)

Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, 05505, South Korea.

Da-Som Kim (DS)

Department of Biomedical Sciences, Asan Medical Center, AMIST, University of Ulsan, College of Medicine, Seoul, 05505, South Korea.

Kyosun Ban (K)

Department of Biomedical Sciences, Asan Medical Center, AMIST, University of Ulsan, College of Medicine, Seoul, 05505, South Korea.

Wonjun Ji (W)

Department of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, 05505, South Korea.

In-Jeoung Baek (IJ)

Department of Cell and Genetic Engineering, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, 05505, South Korea.

Chang-Min Choi (CM)

Department of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, 05505, South Korea.

Jae Cheol Lee (JC)

Department of Oncology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, 05505, South Korea.

Jin Kyung Rho (JK)

Department of Biochemistry and Molecular Biology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, 05505, South Korea. Electronic address: jkrho@amc.seoul.kr.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH